Investigating how eye-tracking and environmental features affect mobility training in toddlers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to explore the impact of combining lightweight head-mounted eye tracking with ROC-Stand training for toddlers with motor delays. It will compare the effects of training with specific environmental features against conventional therapy and training without these features. The study will evaluate outcomes related to body function, daily activities, and family involvement using the ICF framework. Additionally, it will investigate the relationships among children's temperament, motivation, looking behavior, and caregiver-child interactions during the training programs.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. aged between 1 to 3 years
2. having motor delays that either prevent independent walking or require the use of assistive technology for walking, defined as more than 1.5 standard deviations(SD) below the mean, as evaluated by the Chinese Child Development Inventory via a physician
3. able to stand independently for at least two seconds or can tolerate standing with support for up to 10 minutes
4. capable of reaching for objects with either one or both hands
5. with a height ranging from 69 to 103 cm and a weight between 7 to 18 kg
6. having parents who can provide consent for their child's participation in the training programs

Exclusion Criteria:

1. children with severe sensory impairments, such as blindness or deafness
2. children whose height falls outside the range of 69 to 103 cm and weight outside the range of 7 to 18 kg
3. parents or caregivers who are unable to commit the time required for the training phase
4. children who exhibit severe emotional reactions that could potentially lead to harm

Where it's running

• Chang Gung University
  Taoyuan City, Taoyuan County, Taiwan Recruiting

Study contacts

• Principal investigator: Hsiang-Han Huang, ScD — Chang Gung University
• Study coordinator: Hsiang-Han Huang, ScD
• Email: hsianghan@mail.cgu.edu.tw
• Phone: +886-3-2118800

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Web-based therapy using action observation and mirror therapy for arm weakness after stroke

  This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.

  Recruiting Chang Gung Memorial Hospital · Taoyuan · NCT07921108

• Heart rate variability biofeedback, mindfulness, or psychoeducation after knee replacement

  This trial tests whether heart rate variability biofeedback, mindfulness, or psychoeducation help people recover better after total knee arthroplasty.

  Recruiting at 2 sites Chang Gung Memorial Hospital · Taoyuan and 1 other locations · NCT07896954

• Intelligent Sexual Health Help System for Gynecologic Cancer Patients

  A smartphone-based sexual health education and consultation system called LillyBot will be tested with gynecologic cancer patients to see if it improves sexual well-being.

  Recruiting Chang Gung Memorial Hospital · Taoyuan, Guishan · NCT07794098

• Hyperpolarized 13C-MMRI and Metabolomics in Rectal Cancer

  This study tests whether a special MRI method and metabolic analysis can better predict how rectal cancer responds to chemoradiotherapy.

  Recruiting Chang Gung Memorial Hospital · Taoyuan · NCT07730541

• Dry Cord Care vs Alcohol Cord Care for Healthy Newborns

  This trial tests whether dry cord care or routine alcohol cord care is better for healthy newborns by looking at infection rates in the umbilical cord.

  Recruiting Chang Gung Memorial Hospital · New Taipei City, Taiwan · NCT07728058

• Dinutuximab-beta with chemotherapy in newly diagnosed high-risk neuroblastoma

  This pilot study tests whether adding the antibody dinutuximab-beta to standard induction chemotherapy is safe and helps shrink tumors in kids and young adults with newly diagnosed high-risk neuroblastoma.

  Recruiting at 2 sites Phase 1 Chang Gung Memorial Hospital · Taipei, Taiwan and 1 other locations · NCT07688252

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.